The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study
Top Cited Papers
Open Access
- 21 October 2009
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 7 (11), 1767-1773
- https://doi.org/10.1111/j.1538-7836.2009.03588.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- β2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domainJournal of Thrombosis and Haemostasis, 2008
- Clinical Features, Diagnosis, and Management of the Antiphospholipid SyndromeSeminars in Thrombosis and Hemostasis, 2008
- Mechanisms of Disease: antiphospholipid antibodies—from clinical association to pathologic mechanismNature Clinical Practice Rheumatology, 2008
- Invitation to a debate on the serological criteria that define the antiphospholipid syndromeJournal of Thrombosis and Haemostasis, 2008
- Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human β2‐glycoprotein I: Mutation studies including residues R39 to R43Arthritis & Rheumatism, 2007
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Antibody profiles for the diagnosis of antiphospholipid syndromeThrombosis and Haemostasis, 2005
- β2-glycoprotein I–dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndromeBlood, 2004
- Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndromeBlood, 2003
- β2-glycoprotein I-dependent Anticardiolipin Antibodies Preferentially Bind the Amino Terminal Domain of β2-glycoprotein IThrombosis and Haemostasis, 2001